感音神经性听力损失对儿童胚胎性脑肿瘤幸存者神经认知与适应功能的影响
本研究纳入36例接受颅脊照射(CSI)和顺铂化疗的胚胎性脑肿瘤患者,平均治疗后6.7年评估,其中17例存在感音神经性听力损失(SNHL),19例听力正常(NH)。多变量分析显示SNHL与更差的整体智力功能(p=0.027)和知觉推理(p=0.016)相关,但对适应功能无影响。
要点
- SNHL与儿童胚胎性脑肿瘤幸存者更差的整体智力功能相关(p=0.027)。
- SNHL与更差的知觉推理表现相关(p=0.016)。
- 多变量模型中SNHL对适应功能无显著影响。
核心结论
- 儿童胚胎性脑肿瘤中的SNHL与其他人口学和治疗相关因素共同增加神经认知缺陷风险。
研究设计与样本
- 研究纳入36例接受颅脊照射和顺铂化疗的胚胎性脑肿瘤患者,平均治疗后6.7年评估。
主要发现
- SNHL组17例(评估时平均年龄14.4岁),NH组19例(评估时平均年龄13.8岁)。
- 多变量分析中,SNHL与更差的整体智力功能相关(p=0.027)。
- 多变量分析中,SNHL与更差的知觉推理表现相关(p=0.016)。
- 多变量模型中SNHL对适应功能无影响。
- 诊断时年龄和性别与神经认知测量表现相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Survivors of pediatric embryonal brain tumors (BT) are at high risk for sensorineural hearing loss (SNHL) associated with neurocognitive decline. However, previous studies have not assessed the relationship between SNHL and adaptive functioning. We examined neurocognitive and adaptive functioning in patients with and without SNHL. METHODS: Participants included 36 patients treated for an embryonal BT with craniospinal irradiation (CSI) and cisplatin chemotherapy who were assessed 6.7 years post-treatment on average. The impact of SNHL on neurocognitive performance and parent-rated adaptive functioning was assessed in univariate and multivariate analyses. RESULTS: There were 17 cases with SNHL (mean age at evaluation = 14.4) and 19 cases with NH (mean age at evaluation = 13.8). After accounting for age at diagnosis and additional covariates in multivariable analyses, SNHL was associated with worse overall intellectual functioning (p = 0.027) and perceptual reasoning (p = 0.016) performance. There was no effect of SNHL on adaptive functioning in multivariable models. Age at diagnosis and sex were associated with performance on neurocognitive measures. CONCLUSIONS: SNHL in pediatric embryonal BT is associated with increased risk for neurocognitive deficits in conjunction with other demographic and treatment-related factors.
引用
- Heitzer AM, Villagran AM, Raghubar K, et al. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2019. PMID: 31782051. doi:10.1007/s11060-019-03356-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。